Alopecia Areata After Mogamulizumab Treatment

January 2022 in “ JAAD Case Reports ”

Neel S. Raval, Nora A. Alexander, Karlee De Monnin, Christine C. Yokoyama, Neha Mehta‐Shah, Ilana S. Rosman, Amy Musiek

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on secure.jbs.elsevierhealth.com →

Discuss this study in the Community →

Cited in this study

2 / 2 results

research Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review

10 citations, January 2021 in “Annals of dermatology/Annals of Dermatology”

Nivolumab can cause hair loss as a rare side effect.

Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease

research Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease

30 citations, July 2019 in “PloS one”

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

1 / 1 results

research Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child

April 2019 in “International journal of research in dermatology”

A child with rough nails also had hair loss and allergies.